The clock is ticking on Social Security as we know it. Without major reforms, the program is set to deplete the asset ...

Hemab Therapeutics is advancing antibody-based therapies for rare blood coagulation disorders, targeting subcutaneous ...

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage biotechnology company, announced today preliminary select operational ...

Taiwan Semiconductor reported their Q1 2026 financials today, which beat on both lines, underscoring strong momentum. See why ...

What companies could make sense in an acquisition?

This precision genetic medicine developer reported a notable insider sale as it advances therapies for rare and serious ...

The Kenya Universities and Colleges Central Placement Service (KUCCPS) opened its 2026 placement portal on April 7, kicking ...

Gossamer Bio is picking up the pieces after failing to bring its only late-stage drug to market. The local biotech plans to ...

You've probably heard by now that Treasury bonds are a safe investment. Good news there: They are, in fact, a relatively low-risk way to earn interest on your money. Still, Treasuries are complex ...

There are plenty of reasons, though, to be bullish on the stock, not the least of which is its improved cash position. The ...

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on Wednesday seeking to raise capital ...